No abstract

patients with ruptured aortic aneurysms from treatment should not be excluded. However, a physiological scoring system after 48 h appears justifiable in order to decide on the appropriateness of continual ICU support.

ProCol grafts, used for AV-fistulas, demonstrate acceptable patency rates in high-risk haemodialysis patients. Diabetes mellitus jeopardizes the patency of these fistulas and is associated with a high revision rate.

Surgical therapy in patients with asymptomatic IAA can be performed with a reasonable mortality. However, mortality and morbidity in patients with symptomatic or ruptured IAA remains high. Postoperative long-term results are excellent. The value of endovascular therapy for IAA has yet to be determined.